enVVeno Medical Corp
NVNONasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$20.9M | −$23.8M | −$25.2M | −$24.9M | −$16.9M | −$9.1M |
| Net income | −$19.5M | −$21.8M | −$23.5M | −$24.7M | −$16.5M | −$9.1M |
| Total assets | $29.6M | $45.0M | $48.6M | $41.7M | $57.7M | $10.5M |
| Total liabilities | $2.4M | $2.8M | $2.4M | $2.9M | $3.3M | $3.4M |
| Equity | $27.1M | $42.2M | $46.2M | $38.7M | $54.4M | $7.1M |
| EPS (diluted) | $-33.06 | $-44.53 | $-1.91 | $-2.20 | $-1.90 | — |
| Shares out. | 17.5M | 13.3M | 9.5M | 9.5M | 8.5M | 19.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −71.8%
- Return on assets
- −65.9%
- Return on capital (ROCE)
- −76.2%
- Liabilities / assets
- 8.2%
- Debt / equity
- 0.09×
- Book value / share
- $1.55
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -6.01distress
- Accruals / assets
- −13.2%clean
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 17, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Perceptive Advisors LlcPassive (13G)May 15, 2026
- Kingdon Capital Management, L.L.C.Passive (13G)May 15, 2026
- Braeden LichtiActivist (13D)Feb 20, 2026
- Northstrive Fund Ii LpActivist (13D)Feb 20, 2026
- Satterfield Thomas A JrPassive (13G)Nov 19, 2025
- Nantahala Capital Management, LlcPassive (13G)Nov 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 71,103 | 6.4 | +17.8% |
| Apr 30, 2026 | 60,362 | 4.6 | -20.8% |
| Apr 15, 2026 | 76,169 | 10.0 | +2.0% |
| Mar 31, 2026 | 74,706 | 6.8 | -6.5% |
| Mar 13, 2026 | 79,901 | 3.7 | +7.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Regulation FD disclosure · Other material eventApr 29, 2026
- Results of operations · Other material eventFeb 4, 2026
- Amended charter or bylawsJan 20, 2026
- Shareholder voteDec 12, 2025
- Amended charter or bylawsNov 20, 2025
- Regulation FD disclosureNov 14, 2025
- Entered a material agreementOct 30, 2025
- Delisting / listing-standard noticeOct 10, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- 10-QMay 6, 2026
- 8-KApr 29, 2026
- S-8Mar 26, 2026
- 10-KMar 26, 2026
- 4Mar 13, 2026
- 144Mar 12, 2026
- SCHEDULE 13DFeb 20, 2026
- SCHEDULE 13DFeb 20, 2026
- SCHEDULE 13G/AFeb 17, 2026
- SCHEDULE 13GFeb 10, 2026
- SCHEDULE 13GFeb 10, 2026
- 8-KFeb 4, 2026
- 8-KJan 20, 2026